Recent Trip to China Helps CLSI Foster Business Relationships
Last month, Glen Fine, CLSI CEO, traveled through China to further cultivate business relationships with various stakeholders within the Chinese academic, business, and health care systems. His trip started with a visit to Sun Yat-sen University (SYU), Zhongsan Medical School, and DaAn Health in Guangdong Province, to discuss CLSI’s role in global standards development and its role in the International Organization for Standardization (ISO) Technical Committee 212. While at SYU/DaAn Health, he learned about their vision and business goals, and the strong value of their CLSI membership. He also explored ways in which CLSI can assist with the Chinese national health care reforms, most notably at the community health care levels, in enhancing the quality and standards for their medical laboratory operations.
With the evolving growth of CLSI memberships in China, the organization is gaining not only talented volunteers to help develop globally applicable standards, but also additional perspectives. In China, there is currently a large focus for medical laboratories at all levels to receive accreditation from Chinese and/or international organizations. CLSI is excited to help support these efforts with its consensus standards and training.
Mr. Fine also traveled to the city of Qingdao where he toured a Tier-2 hospital, made presentations, and met with senior governmental ministry of health officials. The facility visited wants to increase its capabilities and is viewed as a model site as it improves to become the first Tier-2 health care facility laboratory to become accredited in China. Mr. Fine received a warm welcome when he presented information about CLSI and laboratory standards to the organization’s president, regional Health Care Minister, and other dignitaries.
As with past international trips, this most recent visit was a successful and informative way for CLSI to continue to learn and partner with international organizations to improve standards for quality patient care worldwide.
Access this month’s newsletter featuring the updates on all CLSI program areas.
Performance Standards for Antimicrobial Susceptibility Testing; Twenty-Fifth Informational Supplement
Includes M02-A12 and M07-A10!
The Fundamentals for Implementing a Quality Management System (QMS) in the Clinical Laboratory
Fluorescence In Situ Hybridization Methods for Clinical Laboratories; Approved Guideline—Second Edition